title: BAYRY Begins Phase I Study With KQB548 in KRAS-Mutated Cancers
source: Yahoo
date: 2025-10-09
url: https://finnhub.io/api/news?id=eb8e22e6821a054465a3b4e7ffe55f5f841c8c91d3477d9950c0909da9dd653c
Bayer and Kumquat launch a phase I study of KQB548, aiming to target various KRAS G12D-mutated tumors like pancreatic, colorectal and lung cancer.
